Accéder au contenu
Merck

Injectable and in situ gelling hydrogels for modified protein release.

European biophysics journal : EBJ (2009-03-28)
L Pescosolido, S Miatto, C Di Meo, C Cencetti, T Coviello, F Alhaique, Pietro Matricardi
RÉSUMÉ

A novel injectable polysaccharide system based on calcium Alginate (Ca-Alg) hydrogel and two Dextran methacrylate derivatives (DexMA) was recently developed. The resulting Interpenetrating Polymer Network showed a synergistic mechanical behavior that can be exploited to target the hydrogel properties towards specific biomedical needs. In the present paper, hydrogels composed of 3% (w/v) Ca-Alg and Dextran (Mw 40 x 10(4) and 500 x 10(4)), derivatized with methacrylic groups (derivatization degrees 5 and 30%) at concentrations 5% (w/v), were characterized. The data reported here evidenced that Mw and derivatization degree of Dex chains can deeply affect the mechanical as well a model protein (Horseradish peroxidase) delivery rate. The enzymatic activity of such model protein was never significantly altered by the adopted experimental conditions.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Silicone oil AP 150, viscosity ~150 mPa.s,   neat(25 °C)